Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.
Douglas RS, Tsirbas A, Gordon M, Lee D, Khadavi N, Garneau HC, Goldberg RA, Cahill K, Dolman PJ, Elner V, Feldon S, Lucarelli M, Uddin J, Kazim M, Smith TJ, Khanna D; International Thyroid Eye Disease Society. Douglas RS, et al. Arch Ophthalmol. 2009 Sep;127(9):1155-60. doi: 10.1001/archophthalmol.2009.232. Arch Ophthalmol. 2009. PMID: 19752424 Free PMC article.
Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series.
Kauh CY, Gupta S, Douglas RS, Elner VM, Nelson CC, Niziol LM, Kahana A. Kauh CY, et al. Among authors: douglas rs. Ophthalmic Plast Reconstr Surg. 2015 Sep-Oct;31(5):385-90. doi: 10.1097/IOP.0000000000000356. Ophthalmic Plast Reconstr Surg. 2015. PMID: 25533274 Free PMC article.
Eyelid Swelling and Proptosis with Systemic Implications.
Al-Holou SN, Elner VM, Douglas RS, Joseph SS. Al-Holou SN, et al. Among authors: douglas rs. Am J Med. 2016 Jul;129(7):e51-3. doi: 10.1016/j.amjmed.2016.01.027. Epub 2016 Feb 8. Am J Med. 2016. PMID: 26868858 No abstract available.
A New Era in the Treatment of Thyroid Eye Disease.
Patel A, Yang H, Douglas RS. Patel A, et al. Among authors: douglas rs. Am J Ophthalmol. 2019 Dec;208:281-288. doi: 10.1016/j.ajo.2019.07.021. Epub 2019 Aug 1. Am J Ophthalmol. 2019. PMID: 31377284 Free article. Review.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.
Kahaly GJ, Dolman PJ, Wolf J, Giers BC, Elflein HM, Jain AP, Srinivasan A, Hadjiiski L, Jordan D, Bradley EA, Stan MN, Eckstein A, Pitz S, Vorländer C, Wester ST, Nguyen J, Tucker N, Sales-Sanz M, Feldon SE, Nelson CC, Hardy I, Abia-Serrano M, Tedeschi P, Janes JM, Xu J, Vue P, Macias WL, Douglas RS. Kahaly GJ, et al. Among authors: douglas rs. J Clin Endocrinol Metab. 2023 Nov 17;108(12):3122-3134. doi: 10.1210/clinem/dgad381. J Clin Endocrinol Metab. 2023. PMID: 37390454 Free PMC article. Clinical Trial.
128 results